-transparent.png){kind=logo}
We conducted a double-blind, randomized crossover trial to evaluate whether oral terbutaline (2.5 mg orally three times daily for a week) increased the force of diaphragmatic contraction in normocapnic patients with chronic obstructive pulmonary disease. Ten patients with moderate to severe airway obstruction completed the trail. Compared with placebo, terbutaline produced a mean increase of 5.8 cmH2O in peak inspiratory mouth pressure and a mean increase of 5.0 cmH2O in transdiaphragmatic pressure during a maximal inspiratory manoeuvre. These small changes with terbutaline failed to achieve statistical significance. Also, terbutaline failed to alter flow rates (FEV1, Vmax50) or patients' dyspnoea ratings using two separate clinical scales (Pneumoconiosis Research Unit Score and the Modified Dyspnoea Index). Because all observed changes in respiratory muscle strength were small and because the trial had power to detect small changes in inspiratory mouth pressures, we suggest that oral terbutaline at the dose administered in this study has little noteworthy effect on respiratory muscle strength in normocapnic patients with chronic obstructive pulmonary disease.
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
April 2019,
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
April 2020,
The clinical respiratory journal,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
January 2016,
PloS one,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
July 1996,
The European respiratory journal,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
September 2017,
American journal of respiratory and critical care medicine,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
February 2006,
European journal of clinical nutrition,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
January 2015,
PloS one,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
May 2020,
American journal of respiratory and critical care medicine,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
August 2020,
Heliyon,
J K Stoller, and
H P Wiedemann, and
J Loke, and
P Snyder, and
J Virgulto, and
R A Matthay
August 2011,
Current therapeutic research, clinical and experimental,
